US2004077527A1PendingUtilityA1

Purified insulin composition

Priority: Apr 15, 1998Filed: Nov 21, 2003Published: Apr 22, 2004
Est. expiryApr 15, 2018(expired)· nominal 20-yr term from priority
Inventors:Are Bogsnes
C07K 1/20
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention concerns a process of chromatographically separating glycosylated proteins from non-glycosylated proteins by subjecting a solution comprising glycolsylated and non-glycosylated proteins to chromatography using a Ca ++ containing eluant. By using this process a fraction comprising non-glycosylated proteins substantially free from glycosylated proteins is obtained. The process may be applied to the separation of proteins used in the medical industry, such as insulin.

Claims

exact text as granted — not AI-modified
1 . A composition comprising recombinant insulin or an analogue thereof, wherein (i) said composition comprises about 0.02% to 0.2% glycosylated insulin or insulin analogue and (ii) said recombinant insulin or insulin analogue is produced in a yeast cell.  
     
     
         2 . A composition as defined in  claim 1 , wherein said glycosylated insulin or insulin analogue is mono-glycosylated.

Join the waitlist — get patent alerts

Track US2004077527A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.